EXJADE Side Effects

6956722-1 | Carotid Artery Disease
on Aug 17, 2010 Female patient from UNITED STATES , weighting 140.0 lb, was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: carotid artery disease (What is carotid artery disease?). Exjade dosage: 625 Mg, Qd.

6954946-0 |
Patient was taking Exjade (View Usage). on Aug 25, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 200.6 lb, was diagnosed with neoplasm and. Exjade dosage: 2000 Mg, Qd.

6954924-1 | Dysstasia
Adverse event was reported on Aug 24, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 500 Mg, Daily) was diagnosed with myelodysplastic syndrome, iron overload, nausea (What is nausea?) and. Location: UNITED STATES , weighting 162.0 lb, After Exjade was administered, patient had the following side effects: dysstasia. During the same period patient was treated with COUMADIN (4 Mg, Qd) (View Coumadin Review and Coumadin Label ), COMPAZINE (10 Mg, Q6h Prn) (View Compazine Review and Compazine Label ), CALCIUM CARBONATE W/VITAMIN D NOS (Two 600mg/400mg Tabs,bid) (View Calcium Carbonate W/vitamin D Nos Review and Calcium Carbonate W/vitamin D Nos Label ), MAGNESIUM (400 Mg, Qd) (View Magnesium Review and Magnesium Label ), ALLOPURINOL (100 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), DOCUSATE SODIUM (250 Mg, Qhs Prn) (View Docusate Sodium Review and Docusate Sodium Label ). Patient was hospitalized.

6945389-4 | Malaise
on Aug 16, 2010 Male patient from UNITED STATES , weighting 160.9 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), neoplasm and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: malaise. Exjade dosage: 1500 Mg, Qd. Patient was hospitalized.


6945083-X |
on Aug 25, 2010 Male patient from UNITED STATES , weighting 191.8 lb, was diagnosed with lung neoplasm malignant and was treated with Exjade (View Usage). . Exjade dosage: 1500 Mg Daily.

6945081-6 | Acidosis Hyperchloraemic, Hepatitis, Leukocytosis, Pyrexia
Patient was taking Exjade (View Usage). After Exjade was administered, patient had the following side effects: acidosis hyperchloraemic, hepatitis (What is hepatitis?), leukocytosis, pyrexia on Aug 26, 2010 from GREECE Additional patient health information: Female patient , 50 years of age, was diagnosed with thalassaemia beta and. Exjade dosage: Unk. Patient was hospitalized and became disabled.

6945079-8 |
Adverse event was reported on Aug 25, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 500 Mg) was diagnosed with iron overload and. Location: UNITED STATES , weighting 132.0 lb, . During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), PAXIL (View Paxil Review and Paxil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6945073-7 | Acidosis, Complications Of Bone Marrow Transplant, Respiratory Failure
on Aug 24, 2010 Male patient from UNITED STATES , weighting 143.3 lb, was diagnosed with aplastic anaemia, iron overload and was treated with Exjade (View Usage). Patient had the following side effects: acidosis, complications of bone marrow transplant, respiratory failure. Exjade dosage: 2000 Mg, Qd. Patient was hospitalized.

6944728-8 |
on Aug 25, 2010 Male patient from UNITED STATES , weighting 173.9 lb, was diagnosed with neoplasm and was treated with Exjade (View Usage). . Exjade dosage: 2000 Mg, Qd. Patient was hospitalized.

6944654-4 |
Patient was taking Exjade (View Usage). on Aug 23, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 131.4 lb, was diagnosed with myelodysplastic syndrome and. Exjade dosage: 1250 Mg /daily. During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), LANTUS (View Lantus Review and Lantus Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6941394-2 | Angiopathy, Dermatitis, Dyspnoea Exertional, Oedema Peripheral, Renal Failure, Renal Failure Chronic, Urinary Tract Infection
Adverse event was reported on Aug 12, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 1375 Mg, Daily) was diagnosed with iron metabolism disorder, pain (What is pain?) and. Location: UNITED STATES , weighting 124.6 lb, Patient had the following side effects: angiopathy, dermatitis, dyspnoea exertional, oedema peripheral, renal failure, renal failure chronic, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with AGGRENOX (1 Twice Daily) (View Aggrenox Review and Aggrenox Label ), FUROSEMIDE (60 Mg) (View Furosemide Review and Furosemide Label ), DARVOCET N 100 (100, One Every Four Hours) (View Darvocet-n 100 Review and Darvocet-n 100 Label ), ROCALTROL (0.25 Mcg Daily) (View Rocaltrol Review and Rocaltrol Label ), POTASSIUM CHLORIDE (10 Meg Daily) (View Potassium Chloride Review and Potassium Chloride Label ), RANEXA (500 Mg Twice Daily) (View Ranexa Review and Ranexa Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6941363-2 | Anaemia, Atrial Fibrillation, Cardiac Disorder, Constipation, Dizziness, Fall, Full Blood Count Decreased, Haematochezia, Malaise
on Aug 11, 2010 Male patient from UNITED STATES , weighting 219.7 lb, was diagnosed with iron overload, myelodysplastic syndrome and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: anaemia, atrial fibrillation (What is atrial fibrillation?), cardiac disorder, constipation (What is constipation?), dizziness (What is dizziness?), fall (What is fall?), full blood count decreased, haematochezia, malaise. Exjade dosage: 1500 Mg, Qd. During the same period patient was treated with VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), ASPIRIN (325 Mg, Qd) (View Aspirin Review and Aspirin Label ), FOLIC ACID (Once Daily) (View Folic Acid Review and Folic Acid Label ), LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), LOPRESSOR (25 Mg, Qd) (View Lopressor Review and Lopressor Label ), PERCOCET (Prn) (View Percocet Review and Percocet Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

6940605-7 | Blood Albumin Decreased, Blood Calcium Decreased, Blood Potassium Decreased, Carbon Dioxide Decreased, Extramedullary Haemopoiesis, Haemosiderosis, Hepatic Failure, Protein Total Decreased, Red Blood Cell Count Decreased
on Aug 17, 2010 Male patient from UNITED STATES , weighting 132.3 lb, was diagnosed with iron overload, sickle cell anaemia and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, blood calcium decreased, blood potassium decreased, carbon dioxide decreased, extramedullary haemopoiesis, haemosiderosis, hepatic failure, protein total decreased, red blood cell count decreased. Exjade dosage: 875 Mg, Qd. During the same period patient was treated with PENICILLIN (250 Mg, Bid) (View Penicillin Review and Penicillin Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized and became disabled.

6940421-6 | Dehydration, Oedema Peripheral
Patient was taking Exjade (View Usage). Patient had the following side effects: dehydration, oedema peripheral on Aug 11, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 84.00 lb, was diagnosed with iron metabolism disorder and. Exjade dosage: 750 Mg, Daily. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), SINGULAIR (View Singulair Review and Singulair Label ), EVISTA (View Evista Review and Evista Label ), LASIX (View Lasix Review and Lasix Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ZOCOR (View Zocor Review and Zocor Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6940290-4 |
Adverse event was reported on Aug 23, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 500 Mg) was diagnosed with iron metabolism disorder and. Location: UNITED STATES , weighting 134.0 lb, .

6938212-5 | Anaemia Of Malignant Disease, Aphasia, Cardiac Failure Congestive, Cardiac Valve Vegetation, Carotid Artery Stenosis, Cerebral Artery Embolism, Cerebrovascular Accident, Confusional State, Constipation
on Aug 20, 2010 Female patient from UNITED STATES , weighting 135.4 lb, was diagnosed with constipation (What is constipation?), cardiac failure congestive, metastatic carcinoid tumour, gastrooesophageal reflux disease, hyperlipidaemia and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia of malignant disease, aphasia (What is aphasia?), cardiac failure congestive, cardiac valve vegetation, carotid artery stenosis, cerebral artery embolism, cerebrovascular accident, confusional state, constipation (What is constipation?). Exjade dosage: 500 Mg, Bid. During the same period patient was treated with AMITIZA (24 Meq, Bid) (View Amitiza Review and Amitiza Label ), METOPROLOL (50 Mg Every Other Day) (View Metoprolol Review and Metoprolol Label ), MS CONTIN (2 Po Bid-30mg) (View Ms Contin Review and Ms Contin Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), ZOCOR (10 Mg Daily) (View Zocor Review and Zocor Label ), LEVOTHYROXINE SODIUM (0.075 Mg, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SOLATOL (80 Mg, Bid) (View Solatol Review and Solatol Label ). Patient was hospitalized and became disabled.

6935818-4 | Acute Myeloid Leukaemia, Life Expectancy Shortened
on Aug 09, 2010 Male patient from UNITED STATES , weighting 194.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). Patient had the following side effects: acute myeloid leukaemia, life expectancy shortened. Exjade dosage: 1750 Mg, Qd. During the same period patient was treated with REVLIMID (Unk) (View Revlimid Review and Revlimid Label ), NEULASTA (View Neulasta Review and Neulasta Label ), CUMERS (View Cumers Review and Cumers Label ), VIDOZA (Unk) (View Vidoza Review and Vidoza Label ).

6935708-7 | Asthenia, Blood Bilirubin Increased, Cholelithiasis, Cholestasis, Chromaturia, Crying, Depressive Symptom, Epigastric Discomfort, Faeces Discoloured
Patient was taking Exjade (View Usage). After Exjade was administered, patient had the following side effects: asthenia, blood bilirubin increased, cholelithiasis, cholestasis, chromaturia, crying, depressive symptom, epigastric discomfort, faeces discoloured on Aug 10, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 129.2 lb, was diagnosed with acute myeloid leukaemia, serum ferritin increased and. Exjade dosage: 1500 Mg, Qd. During the same period patient was treated with PROGRAF (Unk) (View Prograf Review and Prograf Label ).

6935706-3 | Angina Pectoris, Blood Creatinine Increased, Glomerular Filtration Rate Decreased, Nausea, Renal Failure
Adverse event was reported on Aug 10, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 1500 Mg/day) was diagnosed with myelodysplastic syndrome, iron overload and. Location: UNITED STATES , weighting 194.0 lb, Patient experienced the following unwanted or unexpected effects: angina pectoris, blood creatinine increased, glomerular filtration rate decreased, nausea (What is nausea?), renal failure. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ISOSORBIDE (View Isosorbide Review and Isosorbide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ). Patient was hospitalized.

6935313-2 | Abdominal Pain Upper, Colectomy, Colostomy, Diverticulitis, Intestinal Resection, Nausea, Serum Ferritin Increased
on Aug 06, 2010 Male patient from UNITED STATES , weighting 165.0 lb, was diagnosed with neoplasm, iron overload and was treated with Exjade (View Usage). Patient had the following side effects: abdominal pain upper, colectomy, colostomy, diverticulitis, intestinal resection, nausea (What is nausea?), serum ferritin increased. Exjade dosage: 1500 Mg, Daily.

6935207-2 |
on Aug 18, 2010 Female patient from UNITED STATES , weighting 119.0 lb, was treated with Exjade (View Usage). . Exjade dosage: 2000 Mg, Qd.

6935206-0 | Homicide
Patient was taking Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: homicide on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 135.8 lb, . Exjade dosage: 1500 Mg Daily.

6935196-0 | Anaemia Of Malignant Disease, Aphasia, Cardiac Valve Vegetation, Carotid Artery Stenosis, Cerebral Artery Embolism, Cerebrovascular Accident, Confusional State, Constipation
Adverse event was reported on Aug 17, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 500 Mg, Bid) was diagnosed with constipation (What is constipation?), cardiac failure congestive, metastatic carcinoid tumour, gastrooesophageal reflux disease, hyperlipidaemia and. Location: UNITED STATES , weighting 135.4 lb, Patient had the following side effects: anaemia of malignant disease, aphasia (What is aphasia?), cardiac valve vegetation, carotid artery stenosis, cerebral artery embolism, cerebrovascular accident, confusional state, constipation (What is constipation?). During the same period patient was treated with AMITIZA (24 Meq, Bid) (View Amitiza Review and Amitiza Label ), METOPROLOL TARTRATE (50 Mg Every Other Day) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MS CONTIN (2 Po Bid-30mg) (View Ms Contin Review and Ms Contin Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), ZOCOR (10 Mg Daily) (View Zocor Review and Zocor Label ), LEVOTHYROXINE SODIUM (0.075 Mg, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized and became disabled.

6935192-3 | Emphysema
on Aug 17, 2010 Female patient from UNITED STATES , weighting 116.8 lb, was diagnosed with haemochromatosis and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: emphysema. Exjade dosage: 3000 Mg, Qd.

6935120-0 | Pancytopenia, Pulmonary Embolism, Pyrexia, Sepsis
on Aug 13, 2010 Female patient from UNITED STATES , weighting 154.3 lb, was diagnosed with iron overload and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia, pulmonary embolism (What is pulmonary embolism?), pyrexia, sepsis (What is sepsis?). Exjade dosage: Unk. Patient was hospitalized.

6935094-2 |
Patient was taking Exjade (View Usage). on Aug 12, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 168.3 lb, was diagnosed with chronic myeloid leukaemia and. Exjade dosage: 1625 Mg/day.

6935084-X | Metastases To Bone Marrow, Small Cell Lung Cancer Metastatic
Adverse event was reported on Aug 12, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 1250 Mg, Qd) was diagnosed with myelodysplastic syndrome and. Location: UNITED STATES , weighting 122.0 lb, After Exjade was administered, patient had the following side effects: metastases to bone marrow, small cell lung cancer metastatic.

6935077-2 | Serum Ferritin Increased
on Aug 11, 2010 Male patient from UNITED STATES , weighting 111.5 lb, was diagnosed with sickle cell anaemia, pneumococcal infection, convulsion and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: serum ferritin increased. Exjade dosage: 200 Mg, Qd. During the same period patient was treated with PEN VEE K (250 Mg, Bid) (View Pen-vee K Review and Pen-vee K Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), DEPAKOTE (2 Tabs Bid) (View Depakote Review and Depakote Label ).

6934954-6 | Pancytopenia, Pulmonary Embolism, Pyrexia, Sepsis
on Aug 13, 2010 Female patient from UNITED STATES , weighting 154.3 lb, was diagnosed with iron overload and was treated with Exjade (View Usage). Patient had the following side effects: pancytopenia, pulmonary embolism (What is pulmonary embolism?), pyrexia, sepsis (What is sepsis?). Exjade dosage: Unk. Patient was hospitalized.

6934884-X | Renal Disorder
Patient was taking Exjade (View Usage). After Exjade was administered, patient had the following side effects: renal disorder on Aug 06, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 257.5 lb, . Exjade dosage: 1000 Mg, Qd. Patient was hospitalized.

6934869-3 | Bone Marrow Failure, Serum Ferritin Increased, Thrombocytopenia
Adverse event was reported on Aug 06, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 2500 Mg, Unk) was diagnosed with iron overload, sickle cell anaemia, sickle cell anaemia with crisis, pain (What is pain?) and. Location: UNITED STATES , weighting 123.5 lb, Patient experienced the following unwanted or unexpected effects: bone marrow failure, serum ferritin increased, thrombocytopenia. During the same period patient was treated with OXYCONTIN (320 Mg, Unk) (View Oxycontin Review and Oxycontin Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), HYDREA (150 Mg, Bid) (View Hydrea Review and Hydrea Label ). Patient was hospitalized.

6932215-2 | Abdominal Wall Operation, Blood Potassium Increased, Calcinosis, Dialysis, Diarrhoea, Dry Skin, Dysphagia, Headache, Muscle Tightness
on Aug 04, 2010 Female patient from UNITED STATES , weighting 107.0 lb, was treated with Exjade (View Usage). Patient had the following side effects: abdominal wall operation, blood potassium increased, calcinosis, dialysis (What is dialysis?), diarrhoea, dry skin, dysphagia, headache (What is headache?), muscle tightness. Exjade dosage: 1500 Mg, Qd. Patient was hospitalized.

6932213-9 | Diarrhoea, Nausea, Rash, Renal Impairment, Visual Impairment, Weight Decreased
on Aug 04, 2010 Male patient from UNITED STATES , weighting 201.0 lb, was diagnosed with iron overload, serum ferritin increased, myelodysplastic syndrome and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: diarrhoea, nausea (What is nausea?), rash (What is rash?), renal impairment, visual impairment, weight decreased. Exjade dosage: 2500 Mg, Qd. During the same period patient was treated with ANTIBIOTICS IV (Unk) (View Antibiotics Iv Review and Antibiotics Iv Label ), DIURETICS (View Diuretics Review and Diuretics Label ), ANTINEOPLASTIC AGENTS (View Antineoplastic Agents Review and Antineoplastic Agents Label ), VIDAZA (75 Mg/m^2 Di-5 Q 250) (View Vidaza Review and Vidaza Label ).

6931326-5 | Hypoglycaemia
Patient was taking Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia on Aug 04, 2010 from BELGIUM Additional patient health information: Male patient , 67 years of age, was diagnosed with myelodysplastic syndrome and. Exjade dosage: Unk. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), ANTIDIABETIC (Unk) (View Antidiabetic Review and Antidiabetic Label ).

6929892-9 | Anaemia, Haemoglobin Decreased, Neutropenia, Pancytopenia, Serum Ferritin Increased, White Blood Cell Count Decreased
Adverse event was reported on Aug 05, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 2000 Mg, Qd) was diagnosed with b precursor type acute leukaemia, iron overload and. Location: UNITED STATES , weighting 242.5 lb, Patient had the following side effects: anaemia, haemoglobin decreased, neutropenia, pancytopenia, serum ferritin increased, white blood cell count decreased. During the same period patient was treated with MERCAPTOPURINE (Unk) (View Mercaptopurine Review and Mercaptopurine Label ), METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ).

6929781-X | Brain Operation, Discomfort, Fall, Gastrointestinal Tube Insertion, Haematuria, Hypophagia, Liver Function Test Abnormal, Muscular Weakness, Pancytopenia
on Aug 04, 2010 Male patient from UNITED STATES , weighting 166.0 lb, was diagnosed with myelodysplastic syndrome, iron overload and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: brain operation, discomfort, fall (What is fall?), gastrointestinal tube insertion, haematuria, hypophagia, liver function test abnormal, muscular weakness, pancytopenia. Exjade dosage: 1500 Mg, Qd. During the same period patient was treated with LOTRISONE (View Lotrisone Review and Lotrisone Label ), FLOMAX (0.4 Mg, Unk) (View Flomax Review and Flomax Label ), ACETAMINOPHEN (650 Mg, Unk) (View Acetaminophen Review and Acetaminophen Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), KEPPRA (250 Mg, Unk) (View Keppra Review and Keppra Label ), TRAVOPROST (0.004 %, Unk) (View Travoprost Review and Travoprost Label ), COMBIGAN (View Combigan Review and Combigan Label ). Patient was hospitalized.

6925970-9 | Cardiac Arrest
on Aug 13, 2010 Male patient from PHILIPPINES , 80 years of age, was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). Exjade dosage: .

6922945-0 |
Patient was taking Exjade (View Usage). on Aug 11, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 172.0 lb, was diagnosed with iron overload and. Exjade dosage: 1500 Mg Daily.

6922700-1 |
Adverse event was reported on Aug 09, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 2000 Mg Daily) was diagnosed with myelodysplastic syndrome and. Location: UNITED STATES , weighting 165.0 lb, .

6922699-8 | Pollakiuria
on Aug 03, 2010 Male patient from UNITED STATES , weighting 160.9 lb, was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: pollakiuria. Exjade dosage: 1000 Mg, Qd.

6922685-8 | Dyspnoea, Fatigue, Myocardial Infarction, Pallor
on Aug 10, 2010 Male patient from UNITED STATES , weighting 102.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). Patient had the following side effects: dyspnoea, fatigue, myocardial infarction, pallor. Exjade dosage: 1000 Mg, Qd.

6922677-9 |
Patient was taking Exjade (View Usage). on Aug 09, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 173.3 lb, was diagnosed with iron overload and. Exjade dosage: 2000 Mg, Qd.

6921553-5 | Dysphagia, Pyrexia, Skin Discolouration, Throat Irritation, Viral Infection
Adverse event was reported on Aug 02, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 1250 Mg, Daily) was diagnosed with aplastic anaemia, iron overload and. Location: UNITED STATES , weighting 145.0 lb, Patient experienced the following unwanted or unexpected effects: dysphagia, pyrexia, skin discolouration, throat irritation, viral infection (What is viral infection?). Patient was hospitalized.

6921550-X | Constipation
on Aug 03, 2010 Male patient from UNITED STATES , weighting 166.9 lb, was treated with Exjade (View Usage). Patient had the following side effects: constipation (What is constipation?). Exjade dosage: 1000 Mg, Qd. Patient was hospitalized.

6921541-9 |
on Aug 10, 2010 Male patient from UNITED STATES , weighting 152.0 lb, was diagnosed with neoplasm and was treated with Exjade (View Usage). . Exjade dosage: 2000 Mg/daily.

6921530-4 | Haematuria, Nephrolithiasis, Thrombocytopenia
Patient was taking Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: haematuria, nephrolithiasis, thrombocytopenia on Aug 02, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 187.0 lb, was diagnosed with iron overload, pain (What is pain?) and. Exjade dosage: 250 Mg, Tid. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

6921527-4 | Blister, Malaise, Pain, Renal Failure
Adverse event was reported on Aug 02, 2010 by a Male patient taking Exjade (View Usage) (Dosage: Unk) was diagnosed with iron overload and. Location: AUSTRALIA , weighting 125.7 lb, Patient had the following side effects: blister, malaise, pain (What is pain?), renal failure. Patient was hospitalized.

6921409-8 | Abdominal Pain Upper, Anaemia, Aspartate Aminotransferase Increased, Back Pain, Bacterial Infection, Blood Alkaline Phosphatase Increased, Hypertension, Pain In Extremity, Platelet Count Decreased
on Jul 30, 2010 Female patient from UNITED STATES , weighting 150.3 lb, was diagnosed with sickle cell anaemia and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: abdominal pain upper, anaemia, aspartate aminotransferase increased, back pain (What is back pain?), bacterial infection (What is bacterial infection?), blood alkaline phosphatase increased, hypertension, pain in extremity, platelet count decreased. Exjade dosage: 500 Mg, Tid. During the same period patient was treated with NORVASC (10 Mg, Daily) (View Norvasc Review and Norvasc Label ), FLEXERIL (10 Mg, Tid) (View Flexeril Review and Flexeril Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), TAGAMET (400 Mg, Bid) (View Tagamet Review and Tagamet Label ), ATIVAN (1 Mg, Bid) (View Ativan Review and Ativan Label ), LOMOTIL (View Lomotil Review and Lomotil Label ), SINGULAIR (10 Mg, Qd) (View Singulair Review and Singulair Label ). Patient was hospitalized.

6920839-8 | Blast Cell Count Decreased, Blood Iron Increased, Bone Marrow Failure, Cardiac Failure, Cough, Electrocardiogram Qt Prolonged, Fatigue, Full Blood Count Decreased, Malignant Neoplasm Progression
on Aug 09, 2010 Male patient from UNITED STATES , weighting 206.0 lb, was diagnosed with acute myeloid leukaemia, iron overload and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: blast cell count decreased, blood iron increased, bone marrow failure, cardiac failure, cough, electrocardiogram qt prolonged, fatigue, full blood count decreased, malignant neoplasm progression. Exjade dosage: 2000 Mg, Qd. During the same period patient was treated with GEMTUZUMAB (Unk) (View Gemtuzumab Review and Gemtuzumab Label ), CYTARABINE (Unk) (View Cytarabine Review and Cytarabine Label ), IDARUBICIN HCL (Unk) (View Idarubicin Hcl Review and Idarubicin Hcl Label ). Patient was hospitalized.

6919959-3 | Back Pain, Diarrhoea, Fall, Nausea
Patient was taking Exjade (View Usage). Patient had the following side effects: back pain (What is back pain?), diarrhoea, fall (What is fall?), nausea (What is nausea?) on Jul 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 115.9 lb, was diagnosed with sideroblastic anaemia, iron metabolism disorder and. Exjade dosage: Unk. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), TIMOPTIC (View Timoptic Review and Timoptic Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ). Patient was hospitalized.